KR20220098049A - 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 - Google Patents

피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 Download PDF

Info

Publication number
KR20220098049A
KR20220098049A KR1020227022241A KR20227022241A KR20220098049A KR 20220098049 A KR20220098049 A KR 20220098049A KR 1020227022241 A KR1020227022241 A KR 1020227022241A KR 20227022241 A KR20227022241 A KR 20227022241A KR 20220098049 A KR20220098049 A KR 20220098049A
Authority
KR
South Korea
Prior art keywords
composition
nicotinamide riboside
skin
salt
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227022241A
Other languages
English (en)
Korean (ko)
Inventor
앤 데렌-르위스
트로이 로네무스
Original Assignee
크로마덱스 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크로마덱스 아이엔씨. filed Critical 크로마덱스 아이엔씨.
Publication of KR20220098049A publication Critical patent/KR20220098049A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
KR1020227022241A 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 Ceased KR20220098049A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361897713P 2013-10-30 2013-10-30
US61/897,713 2013-10-30
KR1020217026414A KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
PCT/US2014/063260 WO2015066382A1 (en) 2013-10-30 2014-10-30 Nicotinamide riboside compositions for topical use in treating skin conditions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020217026414A Division KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Publications (1)

Publication Number Publication Date
KR20220098049A true KR20220098049A (ko) 2022-07-08

Family

ID=53005146

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020227022241A Ceased KR20220098049A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
KR1020217026414A Ceased KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
KR1020167014302A Ceased KR20160067195A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020217026414A Ceased KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
KR1020167014302A Ceased KR20160067195A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Country Status (12)

Country Link
US (2) US10688118B2 (enExample)
EP (1) EP3063163B1 (enExample)
JP (1) JP6509844B2 (enExample)
KR (3) KR20220098049A (enExample)
CN (2) CN105873937A (enExample)
AU (1) AU2014342185B2 (enExample)
CA (1) CA2928656C (enExample)
ES (1) ES2925879T3 (enExample)
MX (2) MX385305B (enExample)
NZ (1) NZ719328A (enExample)
WO (1) WO2015066382A1 (enExample)
ZA (1) ZA201603314B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016015997A (es) * 2014-06-02 2017-04-05 Glaxosmithkline Intellectual Property (No 2) Ltd Preparacion y uso de beta-d-nicotinamida ribosido cristalina.
CN106715455A (zh) 2014-06-06 2017-05-24 葛兰素史密斯克莱知识产权（第2 号）有限公司 烟酰胺核苷类似物及其药物组合物和用途
CA2956163C (en) 2014-07-24 2023-01-10 W.R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
WO2016144660A1 (en) 2015-03-09 2016-09-15 W.R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
EP3271370B1 (en) * 2015-03-16 2023-06-21 Chromadex Inc. Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof
US20160317419A1 (en) * 2015-05-01 2016-11-03 The Procter & Gamble Company Method of improving skin health and compositions therefor
US20160317418A1 (en) 2015-05-01 2016-11-03 The Procter & Gamble Company Method of improving the appearance of skin and compositions therefor
EP3288530A1 (en) 2015-05-01 2018-03-07 The Procter and Gamble Company Method of improving the appearance of skin and compositions therefor using nicotinamide riboside
AU2016274126A1 (en) 2015-06-10 2018-01-18 Elysium Health, Inc. Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
US20180177703A1 (en) * 2015-06-25 2018-06-28 N.V. Perricone Llc Niacinamide Mononucleotide Formulations For Skin Aging
WO2017004102A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
WO2017004101A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Skin care compositions comprising particles with nicotinamide riboside and methods of using the same
US20160374918A1 (en) * 2015-06-29 2016-12-29 The Procter & Gamble Company Encapsulated skin care agent
CA3010730C (en) 2016-01-11 2021-02-16 The Procter & Gamble Company Method of treating a skin condition and compositions therefor
AU2017232930B2 (en) 2016-03-16 2021-03-25 ChromaDex Inc. B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
CA3021571C (en) * 2016-04-20 2023-01-03 ChromaDex Inc. Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+increasing precursors
CN109982706A (zh) 2016-08-22 2019-07-05 益力舒健康公司 用于治疗神经退行性病症的烟酰胺核苷和紫檀芪的组合物和方法
NZ803738A (en) 2016-11-11 2024-05-31 Chromadex Inc Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
JP7136795B2 (ja) 2016-11-29 2022-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
US11337908B2 (en) 2016-12-21 2022-05-24 Conopco, Inc. Personal care compositions with cystine
CA3046037A1 (en) 2016-12-21 2018-06-28 Unilever Plc Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
EA201991003A1 (ru) 2016-12-21 2019-12-30 Юнилевер Н.В. Композиции для личной гигиены, содержащие малорастворимые соединения
EA038885B1 (ru) 2016-12-21 2021-11-02 ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. Осветляющая кожу добавка для местного применения и композиция с аминокислотами и никотинамидными соединениями
RU2651047C1 (ru) * 2017-05-04 2018-04-18 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственная композиция цитопротекторного действия и способ ее получения
WO2018213715A1 (en) * 2017-05-18 2018-11-22 Elysium Health, Inc. Methods and compositions for improving sleep
US11286274B2 (en) 2017-06-19 2022-03-29 Mitopower Llc Nicotinamide riboside derivatives and their uses
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
CN111542312A (zh) * 2017-07-28 2020-08-14 老龄化控制中心股份公司 预防和逆转衰老方面的组合物和方法
WO2019054485A1 (ja) * 2017-09-14 2019-03-21 めぐみ 田中 老化防止剤及び老化防止方法
GB201716391D0 (en) * 2017-10-06 2017-11-22 Xobaderm Ltd Kit for delivery of an active compound into a biological barrier
US11414407B2 (en) 2017-12-22 2022-08-16 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
US11052100B2 (en) * 2018-08-17 2021-07-06 Bontac Bio-Engineering (Shenzhen) Co., Ltd Stable nicotinamide riboside composition and preparation method thereof
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
EP3897666A2 (en) 2018-12-17 2021-10-27 Mitopower LLC Nicotinyl riboside compounds and their uses
IL289941B2 (en) * 2019-07-19 2025-07-01 Biosynth Ag Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
CN110638827A (zh) * 2019-10-17 2020-01-03 泓博元生命科技（深圳）有限公司 Nadh及其盐在制备皮肤色素抑制剂中的应用
CN111166760A (zh) * 2019-12-17 2020-05-19 浙江安赛新材料科技有限公司 β-烟酰胺单核苷酸或其前体的组合物及制备方法、应用
KR102315139B1 (ko) 2019-12-17 2021-10-20 주식회사 휴메딕스 지방아민 컨쥬게이션된 니코틴아미드 리보사이드 유도체
CN111184732B (zh) * 2020-03-04 2023-09-08 武汉华纳联合药业有限公司 一种复合组合物制剂及其制备方法和皮肤炎症中的应用
CN111454311B (zh) * 2020-04-03 2021-10-19 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其组合物与制备方法
FR3110410A1 (fr) * 2020-05-20 2021-11-26 Nuvamid Sa Compositions cosmétiques anti-âge comprenant de la NMN
WO2021234009A1 (fr) * 2020-05-20 2021-11-25 Nuvamid Sa Compositions cosmetiques anti-age comprenant du nmn
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin
CN111632049A (zh) * 2020-06-09 2020-09-08 西北农林科技大学 一种通过综合矫正细胞活性氧簇代谢紊乱以缓解睾丸衰老损伤的复合配方
WO2022047182A1 (en) * 2020-08-28 2022-03-03 University Of Washington High dose nicotinamide adenine dinucleotide (nad) precursor regimens for reduction of inflammation in human patients with preexisting inflammation
US20240059727A1 (en) * 2021-01-19 2024-02-22 Biosynth Ag Method of making nicotinamide ribofuranoside salts by salt metathesis, the crystalline form of its tosylate salt and the co-crystallized form of its chloride:iodide salt
US12150461B2 (en) * 2021-05-04 2024-11-26 Sovida Solutions Ltd. Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof
CN114129509B (zh) * 2021-12-03 2023-12-01 药酚享科技(北京)有限公司 一种保湿性nmn亲水凝胶剂及其制备方法
CN116621898A (zh) * 2022-04-13 2023-08-22 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其结晶形态、制备方法与用途
KR102784901B1 (ko) * 2022-06-23 2025-03-21 제너럴바이오(주) Nr, nmn 및 nad를 함유한 피부 주름 개선용 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100369602C (zh) * 2001-02-22 2008-02-20 荷兰联合利华有限公司 改进的皮肤用组合物
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
EP1723227A4 (en) 2004-02-10 2007-09-19 Dartmouth College NICOTINAMIDRIBOSIDE KINASE COMPOSITIONS AND METHOD FOR THEIR USE
EP3006040B1 (en) 2004-06-04 2017-11-22 Washington University Methods and compositions for treating neuropathies
US20060229265A1 (en) 2005-03-30 2006-10-12 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
WO2007008548A2 (en) * 2005-07-07 2007-01-18 Sirtris Pharmaceuticals, Inc. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
CN101257897A (zh) * 2005-07-07 2008-09-03 西特里斯药业公司 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物
ES2670927T3 (es) 2005-11-18 2018-06-04 Cornell Research Foundation, Inc. Composiciones de nicotinoil ribósido y métodos de uso
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
US20090069444A1 (en) 2007-09-07 2009-03-12 The United States Of America, As Represented By Th E Secretary Of Agriculture Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
KR101807328B1 (ko) * 2010-01-06 2017-12-08 가부시키가이샤 야쿠르트 혼샤 경구용 ｄｎａ 손상 수복 촉진제 및 엘라스타아제 활성 억제제

Also Published As

Publication number Publication date
CA2928656C (en) 2020-07-28
EP3063163A4 (en) 2017-05-10
CA2928656A1 (en) 2015-05-07
US11033568B2 (en) 2021-06-15
EP3063163B1 (en) 2022-08-10
JP2016538271A (ja) 2016-12-08
NZ719328A (en) 2022-04-29
CN109985056A (zh) 2019-07-09
MX2016005574A (es) 2016-12-09
AU2014342185B2 (en) 2019-01-03
CN105873937A (zh) 2016-08-17
JP6509844B2 (ja) 2019-05-08
KR20160067195A (ko) 2016-06-13
KR20210107895A (ko) 2021-09-01
EP3063163A1 (en) 2016-09-07
US10688118B2 (en) 2020-06-23
US20200289536A1 (en) 2020-09-17
ES2925879T3 (es) 2022-10-20
MX2021009652A (es) 2022-07-26
MX385305B (es) 2025-03-18
US20160250241A1 (en) 2016-09-01
MX394291B (es) 2025-03-24
WO2015066382A1 (en) 2015-05-07
ZA201603314B (en) 2017-09-27

Similar Documents

Publication Publication Date Title
US11033568B2 (en) Nicotinamide riboside compositions for topical use in treating skin conditions
AU2014342185A1 (en) Nicotinamide riboside compositions for topical use in treating skin conditions
Mir-Palomo et al. Inhibition of skin inflammation by baicalin ultradeformable vesicles
KR101715631B1 (ko) 피부 관리를 위한 조성물 및 방법
RU2654804C2 (ru) Антиоксидантные композиции и способы их применения
ES2316647T3 (es) Composiciones para el tratamiento anti-irritante de la rosacea.
US8911774B2 (en) Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
JP2011500597A (ja) 皮膚病又は皮膚病変の治療方法及び組成物
KR20240009434A (ko) 니코틴아미드 아데닌 디뉴클레오티드 (nad) 조성물, 이의 제조 방법 및 이의 사용 방법
ITMI20111806A1 (it) Composizione per il trattamento delle lesioni cutanee
US20160354411A1 (en) Olivamine-induced improvement in endothelial cells viability and function
US10071042B2 (en) External dermatological agent for anti-ageing
HK40011054A (en) Nicotinamide nucleoside composition for topical use in the treatment of dermatosis
US20180185259A1 (en) Methods of treating hyperpigmentation disorders
BR112018011580B1 (pt) Compostos de éster, compostos de amida, composição e uso de pelo menos um composto
US20110274775A1 (en) Extracts of southernwood and topical uses thereof
KR101326026B1 (ko) 펩타이드 유도체를 함유하는 화장료 조성물
JP2007153863A (ja) 毛髪改善外用剤
JP2015229658A (ja) セラミド合成促進剤
MX2007006059A (es) Composicion de crema desmanchadora de piel.
Octavio Inhibition of skin inflammation by baicalin
BR102016022420A2 (pt) Composição tópica, uso cosmético da composição e composição tópica e dermatológica

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220629

Application number text: 1020217026414

Filing date: 20210819

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220801

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230102

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220801

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I